1 Study Coverage
    1.1 Blood Glucose Device Product Introduction
    1.2 Market by Type
        1.2.1 Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Blood Glucose Monitors
        1.2.3 Glucose Monitoring Strips
        1.2.4 Lancets
    1.3 Market by Application
        1.3.1 Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostics
        1.3.4 Home Settings
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Blood Glucose Device Sales Estimates and Forecasts 2017-2028
    2.2 Global Blood Glucose Device Revenue Estimates and Forecasts 2017-2028
    2.3 Global Blood Glucose Device Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Blood Glucose Device Sales by Region
        2.4.1 Global Blood Glucose Device Sales by Region (2017-2022)
        2.4.2 Global Sales Blood Glucose Device by Region (2023-2028)
    2.5 Global Blood Glucose Device Revenue by Region
        2.5.1 Global Blood Glucose Device Revenue by Region (2017-2022)
        2.5.2 Global Blood Glucose Device Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Blood Glucose Device Sales by Manufacturers
        3.1.1 Global Top Blood Glucose Device Manufacturers by Sales (2017-2022)
        3.1.2 Global Blood Glucose Device Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blood Glucose Device in 2021
    3.2 Global Blood Glucose Device Revenue by Manufacturers
        3.2.1 Global Blood Glucose Device Revenue by Manufacturers (2017-2022)
        3.2.2 Global Blood Glucose Device Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Blood Glucose Device Revenue in 2021
    3.3 Global Blood Glucose Device Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Blood Glucose Device Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Blood Glucose Device Sales by Type
        4.1.1 Global Blood Glucose Device Historical Sales by Type (2017-2022)
        4.1.2 Global Blood Glucose Device Forecasted Sales by Type (2023-2028)
        4.1.3 Global Blood Glucose Device Sales Market Share by Type (2017-2028)
    4.2 Global Blood Glucose Device Revenue by Type
        4.2.1 Global Blood Glucose Device Historical Revenue by Type (2017-2022)
        4.2.2 Global Blood Glucose Device Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Blood Glucose Device Revenue Market Share by Type (2017-2028)
    4.3 Global Blood Glucose Device Price by Type
        4.3.1 Global Blood Glucose Device Price by Type (2017-2022)
        4.3.2 Global Blood Glucose Device Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Blood Glucose Device Sales by Application
        5.1.1 Global Blood Glucose Device Historical Sales by Application (2017-2022)
        5.1.2 Global Blood Glucose Device Forecasted Sales by Application (2023-2028)
        5.1.3 Global Blood Glucose Device Sales Market Share by Application (2017-2028)
    5.2 Global Blood Glucose Device Revenue by Application
        5.2.1 Global Blood Glucose Device Historical Revenue by Application (2017-2022)
        5.2.2 Global Blood Glucose Device Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Blood Glucose Device Revenue Market Share by Application (2017-2028)
    5.3 Global Blood Glucose Device Price by Application
        5.3.1 Global Blood Glucose Device Price by Application (2017-2022)
        5.3.2 Global Blood Glucose Device Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Blood Glucose Device Market Size by Type
        6.1.1 North America Blood Glucose Device Sales by Type (2017-2028)
        6.1.2 North America Blood Glucose Device Revenue by Type (2017-2028)
    6.2 North America Blood Glucose Device Market Size by Application
        6.2.1 North America Blood Glucose Device Sales by Application (2017-2028)
        6.2.2 North America Blood Glucose Device Revenue by Application (2017-2028)
    6.3 North America Blood Glucose Device Market Size by Country
        6.3.1 North America Blood Glucose Device Sales by Country (2017-2028)
        6.3.2 North America Blood Glucose Device Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Blood Glucose Device Market Size by Type
        7.1.1 Europe Blood Glucose Device Sales by Type (2017-2028)
        7.1.2 Europe Blood Glucose Device Revenue by Type (2017-2028)
    7.2 Europe Blood Glucose Device Market Size by Application
        7.2.1 Europe Blood Glucose Device Sales by Application (2017-2028)
        7.2.2 Europe Blood Glucose Device Revenue by Application (2017-2028)
    7.3 Europe Blood Glucose Device Market Size by Country
        7.3.1 Europe Blood Glucose Device Sales by Country (2017-2028)
        7.3.2 Europe Blood Glucose Device Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Blood Glucose Device Market Size by Type
        8.1.1 Asia Pacific Blood Glucose Device Sales by Type (2017-2028)
        8.1.2 Asia Pacific Blood Glucose Device Revenue by Type (2017-2028)
    8.2 Asia Pacific Blood Glucose Device Market Size by Application
        8.2.1 Asia Pacific Blood Glucose Device Sales by Application (2017-2028)
        8.2.2 Asia Pacific Blood Glucose Device Revenue by Application (2017-2028)
    8.3 Asia Pacific Blood Glucose Device Market Size by Region
        8.3.1 Asia Pacific Blood Glucose Device Sales by Region (2017-2028)
        8.3.2 Asia Pacific Blood Glucose Device Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Blood Glucose Device Market Size by Type
        9.1.1 Latin America Blood Glucose Device Sales by Type (2017-2028)
        9.1.2 Latin America Blood Glucose Device Revenue by Type (2017-2028)
    9.2 Latin America Blood Glucose Device Market Size by Application
        9.2.1 Latin America Blood Glucose Device Sales by Application (2017-2028)
        9.2.2 Latin America Blood Glucose Device Revenue by Application (2017-2028)
    9.3 Latin America Blood Glucose Device Market Size by Country
        9.3.1 Latin America Blood Glucose Device Sales by Country (2017-2028)
        9.3.2 Latin America Blood Glucose Device Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Blood Glucose Device Market Size by Type
        10.1.1 Middle East and Africa Blood Glucose Device Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Blood Glucose Device Revenue by Type (2017-2028)
    10.2 Middle East and Africa Blood Glucose Device Market Size by Application
        10.2.1 Middle East and Africa Blood Glucose Device Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Blood Glucose Device Revenue by Application (2017-2028)
    10.3 Middle East and Africa Blood Glucose Device Market Size by Country
        10.3.1 Middle East and Africa Blood Glucose Device Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Blood Glucose Device Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories (U.S.)
        11.1.1 Abbott Laboratories (U.S.) Corporation Information
        11.1.2 Abbott Laboratories (U.S.) Overview
        11.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories (U.S.) Recent Developments
    11.2 ARKRAY (Japan)
        11.2.1 ARKRAY (Japan) Corporation Information
        11.2.2 ARKRAY (Japan) Overview
        11.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 ARKRAY (Japan) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 ARKRAY (Japan) Recent Developments
    11.3 Dexcom (U.S.)
        11.3.1 Dexcom (U.S.) Corporation Information
        11.3.2 Dexcom (U.S.) Overview
        11.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Dexcom (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Dexcom (U.S.) Recent Developments
    11.4 F.Hoffmann-La Roche Ltd (Switzerland)
        11.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
        11.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Overview
        11.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
    11.5 Johnson & Johnson (U.S.)
        11.5.1 Johnson & Johnson (U.S.) Corporation Information
        11.5.2 Johnson & Johnson (U.S.) Overview
        11.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson (U.S.) Recent Developments
    11.6 Medtronic (U.S.)
        11.6.1 Medtronic (U.S.) Corporation Information
        11.6.2 Medtronic (U.S.) Overview
        11.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Medtronic (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Medtronic (U.S.) Recent Developments
    11.7 Nipro Diagnostics (U.S.)
        11.7.1 Nipro Diagnostics (U.S.) Corporation Information
        11.7.2 Nipro Diagnostics (U.S.) Overview
        11.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Nipro Diagnostics (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Nipro Diagnostics (U.S.) Recent Developments
    11.8 Terumo Medical Corporation (U.S.)
        11.8.1 Terumo Medical Corporation (U.S.) Corporation Information
        11.8.2 Terumo Medical Corporation (U.S.) Overview
        11.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Terumo Medical Corporation (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Terumo Medical Corporation (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Blood Glucose Device Industry Chain Analysis
    12.2 Blood Glucose Device Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Blood Glucose Device Production Mode & Process
    12.4 Blood Glucose Device Sales and Marketing
        12.4.1 Blood Glucose Device Sales Channels
        12.4.2 Blood Glucose Device Distributors
    12.5 Blood Glucose Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Blood Glucose Device Industry Trends
    13.2 Blood Glucose Device Market Drivers
    13.3 Blood Glucose Device Market Challenges
    13.4 Blood Glucose Device Market Restraints
14 Key Findings in The Global Blood Glucose Device Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Blood Glucose Monitors
    Table 3. Major Manufacturers of Glucose Monitoring Strips
    Table 4. Major Manufacturers of Lancets
    Table 5. Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Blood Glucose Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Blood Glucose Device Sales by Region (2017-2022) & (K Units)
    Table 8. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
    Table 9. Global Blood Glucose Device Sales by Region (2023-2028) & (K Units)
    Table 10. Global Blood Glucose Device Sales Market Share by Region (2023-2028)
    Table 11. Global Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Blood Glucose Device Revenue Market Share by Region (2017-2022)
    Table 13. Global Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Blood Glucose Device Revenue Market Share by Region (2023-2028)
    Table 15. Global Blood Glucose Device Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Blood Glucose Device Sales Share by Manufacturers (2017-2022)
    Table 17. Global Blood Glucose Device Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
    Table 19. Blood Glucose Device Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Blood Glucose Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Blood Glucose Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
    Table 22. Blood Glucose Device Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Blood Glucose Device Product Offered
    Table 24. Date of Manufacturers Enter into Blood Glucose Device Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 27. Global Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 28. Global Blood Glucose Device Sales Share by Type (2017-2022)
    Table 29. Global Blood Glucose Device Sales Share by Type (2023-2028)
    Table 30. Global Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Blood Glucose Device Revenue Share by Type (2017-2022)
    Table 33. Global Blood Glucose Device Revenue Share by Type (2023-2028)
    Table 34. Blood Glucose Device Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Blood Glucose Device Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 37. Global Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 38. Global Blood Glucose Device Sales Share by Application (2017-2022)
    Table 39. Global Blood Glucose Device Sales Share by Application (2023-2028)
    Table 40. Global Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Blood Glucose Device Revenue Share by Application (2017-2022)
    Table 43. Global Blood Glucose Device Revenue Share by Application (2023-2028)
    Table 44. Blood Glucose Device Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Blood Glucose Device Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 47. North America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 48. North America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 51. North America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 52. North America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
    Table 55. North America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
    Table 56. North America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Blood Glucose Device Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Blood Glucose Device Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Blood Glucose Device Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Blood Glucose Device Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Blood Glucose Device Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Blood Glucose Device Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Abbott Laboratories (U.S.) Corporation Information
    Table 107. Abbott Laboratories (U.S.) Description and Major Businesses
    Table 108. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Abbott Laboratories (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Abbott Laboratories (U.S.) Recent Developments
    Table 111. ARKRAY (Japan) Corporation Information
    Table 112. ARKRAY (Japan) Description and Major Businesses
    Table 113. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. ARKRAY (Japan) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. ARKRAY (Japan) Recent Developments
    Table 116. Dexcom (U.S.) Corporation Information
    Table 117. Dexcom (U.S.) Description and Major Businesses
    Table 118. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Dexcom (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Dexcom (U.S.) Recent Developments
    Table 121. F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
    Table 122. F.Hoffmann-La Roche Ltd (Switzerland) Description and Major Businesses
    Table 123. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
    Table 126. Johnson & Johnson (U.S.) Corporation Information
    Table 127. Johnson & Johnson (U.S.) Description and Major Businesses
    Table 128. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Johnson & Johnson (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Johnson & Johnson (U.S.) Recent Developments
    Table 131. Medtronic (U.S.) Corporation Information
    Table 132. Medtronic (U.S.) Description and Major Businesses
    Table 133. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Medtronic (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Medtronic (U.S.) Recent Developments
    Table 136. Nipro Diagnostics (U.S.) Corporation Information
    Table 137. Nipro Diagnostics (U.S.) Description and Major Businesses
    Table 138. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Nipro Diagnostics (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Nipro Diagnostics (U.S.) Recent Developments
    Table 141. Terumo Medical Corporation (U.S.) Corporation Information
    Table 142. Terumo Medical Corporation (U.S.) Description and Major Businesses
    Table 143. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Terumo Medical Corporation (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Terumo Medical Corporation (U.S.) Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Blood Glucose Device Distributors List
    Table 149. Blood Glucose Device Customers List
    Table 150. Blood Glucose Device Market Trends
    Table 151. Blood Glucose Device Market Drivers
    Table 152. Blood Glucose Device Market Challenges
    Table 153. Blood Glucose Device Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blood Glucose Device Product Picture
    Figure 3. Global Blood Glucose Device Market Share by Type in 2021 & 2028
    Figure 3. Blood Glucose Monitors Product Picture
    Figure 4. Glucose Monitoring Strips Product Picture
    Figure 5. Lancets Product Picture
    Figure 6. Global Blood Glucose Device Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Diagnostics
    Figure 9. Home Settings
    Figure 10. Others
    Figure 11. Blood Glucose Device Report Years Considered
    Figure 12. Global Blood Glucose Device Sales 2017-2028 (K Units)
    Figure 13. Global Blood Glucose Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Blood Glucose Device Revenue 2017-2028 (US$ Million)
    Figure 15. Global Blood Glucose Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
    Figure 17. Global Blood Glucose Device Sales Market Share by Region (2023-2028)
    Figure 18. North America Blood Glucose Device Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Blood Glucose Device Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Blood Glucose Device Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Blood Glucose Device Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Blood Glucose Device Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Blood Glucose Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Blood Glucose Device in the World: Market Share by Blood Glucose Device Revenue in 2021
    Figure 30. Global Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 32. Global Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 33. Global Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 34. Global Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 35. North America Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 36. North America Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 37. North America Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 38. North America Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 39. North America Blood Glucose Device Sales Share by Country (2017-2028)
    Figure 40. North America Blood Glucose Device Revenue Share by Country (2017-2028)
    Figure 41. U.S. Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 44. Europe Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 46. Europe Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Blood Glucose Device Sales Share by Country (2017-2028)
    Figure 48. Europe Blood Glucose Device Revenue Share by Country (2017-2028)
    Figure 49. Germany Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 50. France Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Blood Glucose Device Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Blood Glucose Device Revenue Share by Region (2017-2028)
    Figure 60. China Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 63. India Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Blood Glucose Device Sales Share by Country (2017-2028)
    Figure 75. Latin America Blood Glucose Device Revenue Share by Country (2017-2028)
    Figure 76. Mexico Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Blood Glucose Device Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Blood Glucose Device Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Blood Glucose Device Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Blood Glucose Device Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Blood Glucose Device Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Blood Glucose Device Revenue Share by Country (2017-2028)
    Figure 85. Turkey Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Blood Glucose Device Revenue (2017-2028) & (US$ Million)
    Figure 88. Blood Glucose Device Value Chain
    Figure 89. Blood Glucose Device Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed